Rep. Susan Wild Calls on Pharmaceutical Companies to Lower Cost of Inhalers to $35
April 10, 2024
April 10, 2024
WASHINGTON, April 10 -- Rep. Susan Wild, D-Pennsylvania, issued the following news release:
Today, Congresswoman Wild joined Reps. Auchincloss, Schrier, Salinas, and Budzinski to call on all pharmaceutical companies to lower the cost of inhalers to $35 for American customers. This comes after three major companies - AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline - announced they would voluntarily cap the prices of their inhalers at $35.
"All Americans dese . . .
Today, Congresswoman Wild joined Reps. Auchincloss, Schrier, Salinas, and Budzinski to call on all pharmaceutical companies to lower the cost of inhalers to $35 for American customers. This comes after three major companies - AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline - announced they would voluntarily cap the prices of their inhalers at $35.
"All Americans dese . . .